Aspen Neuroscience, Inc. (ASPE) stock analysis
ASPENasdaqPharmaceutical PreparationsFiscal year ends December 31
$13.61−0.21 (-1.52%)
Close on Nov 12, 2026Market cap –P/E –Yield –
Analysis
Not enough annual history yet
Analysis needs at least two fiscal years of reported financials for Aspen Neuroscience.
See a number that looks wrong?